Lenalidomide and Vancomycin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lenalidomide (lenalidomide) and Vancomycin (vancomycin). Common drug interactions include bradycardia among females and pneumonia among males.
The phase IV clinical study analyzes what interactions people have when they take Lenalidomide and Vancomycin. It is created by eHealthMe based on reports of 96 people who take the same drugs from the FDA, and is updated regularly.
What is Lenalidomide?
Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.
What is Vancomycin?
Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.
96 people who take Lenalidomide and Vancomycin together, and have interactions are studied.

What are the common drug interactions of Lenalidomide and Vancomycin, by gender? *:
female:
- Bradycardia (abnormally slow heart action)
- Electrocardiogram qrs complex prolonged
- Hyperkalaemia (damage to or disease of the kidney)
- Klebsiella infection
- Osteonecrosis (death of bone)
- Skin infection
- Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)
- Acute respiratory failure
- Anal abscess
- Asthenia (weakness)
male:
- Pneumonia
- Renal impairment (severely reduced kidney function)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Pharyngitis (inflammation of the pharynx, causing a sore throat)
- Platelet count decreased
- Overdose
- Gastroenteritis (inflammation of stomach and intestine)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Febrile neutropenia (fever with reduced white blood cells)
What are the common drug interactions of Lenalidomide and Vancomycin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Pneumonia
30-39:
n/a
40-49:
- Device related infection
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
- Lower respiratory tract infection
- Metapneumovirus infection (infection with human metapneumovirus)
- Nosocomial infection (infection from hospital)
- Febrile neutropenia (fever with reduced white blood cells)
- Mucosal inflammation (infection of mucous membrane)
- Acute respiratory distress syndrome
- Blood prolactin increased
- Respiratory distress (difficulty in breathing)
50-59:
- Neutropenia (an abnormally low number of neutrophils)
- Ototoxicity (damage to the ear)
- Pneumonia
- Pneumonia mycoplasmal (mycoplasma pneumonia (mp) is a contagious respiratory infection)
- Pneumonia respiratory syncytial viral (respiratory syncytial virus (rsv) is a very common virus that leads to mild, cold-like symptoms in adults and older healthy children)
- Thrombocytopenia (decrease of platelets in blood)
- Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances)
- Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)
- Candida sepsis (candida in blood stream)
- Cytomegalovirus viraemia (cytomegalo virus in blood stream)
60+:
- Pneumonia
- Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
- Hypertension (high blood pressure)
- Influenza
- Malaise (a feeling of general discomfort or uneasiness)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
- Pharyngitis (inflammation of the pharynx, causing a sore throat)
- Platelet count decreased
- Renal impairment (severely reduced kidney function)
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 61 people, 63.54%
- Pneumonia: 13 people, 13.54%
- High Blood Pressure: 10 people, 10.42%
- Fever: 10 people, 10.42%
- Febrile Neutropenia (fever with reduced white blood cells): 9 people, 9.38%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 8 people, 8.33%
- Klebsiella Infection: 8 people, 8.33%
- Insomnia (sleeplessness): 7 people, 7.29%
- Back Pain: 6 people, 6.25%
- Plasmacytoma (neoplasm of plasma cells (usually in bone marrow)): 5 people, 5.21%
* Approximation only. Some reports may have incomplete information.
Do you take Lenalidomide and Vancomycin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Lenalidomide (52,881 reports)
- Vancomycin (17,165 reports)
Browse all drug interactions of Lenalidomide and Vancomycin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lenalidomide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vancomycin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lenalidomide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vancomycin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on lenalidomide and vancomycin (the active ingredients of Lenalidomide and Vancomycin, respectively), and Lenalidomide and Vancomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Zetonna and Nuvigil - 2 seconds ago
- Could Famciclovir cause Duodenal Ulcer Aggravated? - 6 seconds ago
- Drug interactions of Biaxin and Penlac - 6 seconds ago
- Could Clonazepam cause Blood Urea Increased? - 8 seconds ago
- Could Loraz cause Skin Toxicity? - 11 seconds ago
- Could Ziac cause Injury? - 14 seconds ago
- Drug interactions of Cymbalta and Fs - 15 seconds ago
- Could Temsirolimus cause Cerebral Ischaemia? - 19 seconds ago
- Could Loraz cause Sinus Congestion? - 22 seconds ago
- Could Loraz cause Sluggishness? - 23 seconds ago